Brad Stanfield on Quercetin
4 episodes · 8 references · 2022–2023
- Stanfield previously used quercetin 5 days/month as a senolytic but has stopped after new ITP data undermined the original pre-clinical hype. - He acknowledges quercetin's senolytic potential when combined with dasatinib, citing reduced senescent cell burden within 11 days. - No specific dosage amounts discussed; no personal consumption details beyond the 5-day monthly cycling protocol.
Benefits
- Dasatinib plus quercetin reduced senescent cell burden within 11 days in human trials. - The combination can improve age-related frailty and cardiovascular disease. - Stanfield used quercetin specifically to clear old non-dividing senescent cells.
Best Practices
- Stanfield cycled quercetin 5 days per month for the senolytic effect. - Used as part of a periodic dosing protocol rather than daily supplementation. - No specific mg dose or brand discussed in available references.
Cautions
- Stanfield stopped taking quercetin after new Interventions Testing Program data superseded earlier pre-clinical excitement. - He updated his public supplement page to reflect he no longer takes fisetin or quercetin. - The original hype was generated from pre-clinical work that has not been confirmed by newer evidence.
“The combination of dasatinib and quercetin are both potent senolytics and they can improve age-related conditions as well as frailty and cardiovascular disease.”
Quercetin & Fisetin – Why I’ve STOPPED Taking Them
“I use it... to help with the senolytic effect. This is where I'm trying to clear away old cells that are no longer dividing.”
Uric Acid & Dementia Cure: Hype or Hope?
“I'm also going to update my supplement page to reflect that I'm no longer taking fisetin or quercetin.”
Quercetin & Fisetin – Why I’ve STOPPED Taking Them
$0.09/ct
$27.99 total
$0.12/ct
$27.99 total
$0.16/ct
$18.89 total
$0.18/ct
$32.95 total
$0.31/ct
$36.75 total
$0.42/ct
$50.50 total
$0.48/ct
$29.00 total
